Type III TGFβ receptor and Src direct hyaluronan-mediated invasive cell motility.
about
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.Transcriptional Profiling of Cultured, Embryonic Epicardial Cells Identifies Novel Genes and Signaling Pathways Regulated by TGFβR3 In Vitro.Hyaluronan as a therapeutic target in human diseasesCommon pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells.DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.BMP2 rescues deficient cell migration in Tgfbr3(-/-) epicardial cells and requires Src kinase.
P2860
Type III TGFβ receptor and Src direct hyaluronan-mediated invasive cell motility.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Type III TGFβ receptor and Src direct hyaluronan-mediated invasive cell motility.
@en
type
label
Type III TGFβ receptor and Src direct hyaluronan-mediated invasive cell motility.
@en
prefLabel
Type III TGFβ receptor and Src direct hyaluronan-mediated invasive cell motility.
@en
P2093
P2860
P1433
P1476
Type III TGFβ receptor and Src direct hyaluronan-mediated invasive cell motility.
@en
P2093
Daniella Espiritu
Joey V Barnett
Patrick Allison
Todd D Camenisch
P2860
P304
P356
10.1016/J.CELLSIG.2014.11.037
P577
2014-12-11T00:00:00Z